Like a therapeutic option that does not rely on the body’s own immune response, mAbs have value in immunosuppressed individuals and considerable potential as a treatment modality for organ transplant individuals with COVID-19
Like a therapeutic option that does not rely on the body’s own immune response, mAbs have value in immunosuppressed individuals and considerable potential as a treatment modality for organ transplant individuals with COVID-19.2 , 3 To the best of our knowledge, there exists no meta-analysis describing the effect of mAbs on organ transplant recipients with […]